ViiV Healthcare announced 48-week findings from the DOLCE study, sponsored by Fundacion Huesped and the Bahiana Foundation of Infectiology, showing the 2-drug regimen Dovato achieved similar results ...
Results that may be inaccessible to you are currently showing.